Results 61 to 70 of about 68,473 (259)

Phenylketonuria: Protein content and amino acids profile of dishes for phenylketonuric patients. The relevance of phenylalanine [PDF]

open access: yes, 2014
Phenylketonuria is an inborn error of metabolism, involving, in most cases, a deficient activity of phenylalanine hydroxylase. Neonatal diagnosis and a prompt special diet (low phenylalanine and natural-protein restricted diets) are essential to the ...
Almeida, Manuela F.   +5 more
core   +1 more source

Exome sequencing in every pregnancy? Results of trio exome sequencing in structurally normal fetuses

open access: yesPrenatal Diagnosis, Volume 45, Issue 3, Page 276-286, March 2025.
Abstract Objective This study aimed to assess the detection rate of clinically significant results of prenatal exome sequencing (pES) in low‐risk pregnancies and apparently normal fetuses in non‐consanguineous couples. Methods A retrospective analysis of pES conducted at a single center from January 2020 to September 2023 was performed.
Michal Levy   +9 more
wiley   +1 more source

Prenatal Diagnosis of Classical Phenylketonuria with Polymerase Chain Reaction, Automatic Sequencing, and Linkage Analysis with Short Tandem Repeats

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2005
Objective: To share our experience of prenatal classical phenylketonuria (PKU) diagnosis using the polymerase chain reaction (PCR), automatic sequencing, and linkage analysis with short tandem repeats (STRs).
Wei-Min Hu   +5 more
doaj   +1 more source

Evaluating the Influence of Social Determinants of Health on Blood Phenylalanine Levels in Phenylketonuria Patients

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 2, February 2025.
ABSTRACT Phenylketonuria (PKU) is a genetic metabolic disorder that causes the accumulation of phenylalanine (Phe) in tissues, leading to intellectual disability, seizures, and socioemotional challenges. The role of social determinants of health (SDOH) in PKU management has not been formally studied, and this investigation evaluates the association ...
Cassandra Afseth   +6 more
wiley   +1 more source

Erythrocytes as Carriers of Therapeutic Enzymes. [PDF]

open access: yes, 2020
Therapeutic enzymes are administered for the treatment of a wide variety of diseases. They exert their effects through binding with a high affinity and specificity to disease-causing substrates to catalyze their conversion to a non-noxious product, to ...
Bax, BE
core   +1 more source

Developmental maturation and regional heterogeneity but no sexual dimorphism of the murine CNS myelin proteome

open access: yesGlia, Volume 73, Issue 1, Page 38-56, January 2025.
Main Points We analyze myelin purified from mouse CNS tissue by quantitative proteomics. The protein composition of myelin matures between P18 and P75. Regional heterogeneity but no sex‐dependent divergence of the CNS myelin proteome. Abstract The molecules that constitute myelin are critical for the integrity of axon/myelin‐units and thus speed and ...
Sophie B. Siems   +9 more
wiley   +1 more source

25 Hydroxy Vitamin D Level, Bone Health, Vitamin D and Calcium Intake in Chilean Patients with Phenylketonuria and Hyperphenylalaninemias [PDF]

open access: gold, 2021
Cinthya Leiva   +6 more
openalex   +1 more source

Management of Phenylketonuria and Hyperphenylalaninemia [PDF]

open access: yesThe Journal of Nutrition, 2007
Hyperphenylalaninemia (HPA) is the most frequently inherited disorder of amino acid metabolism (prevalence 1:10,000). In France, a nationwide neonatal screening was organized in 1978 to control its efficacy and patient follow-up. Phenylketonuria (PKU) was diagnosed in 81.6% of screened patients, the remaining affected with either non-PKU HPA (17.2%) or
Hélène Ogier, de Baulny   +3 more
openaire   +2 more sources

Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l‐amino acid‐based product

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 1, January 2025.
Abstract Background Phenylketonuria (PKU) is caused by phenylalanine hydroxylase deficiency. Treatment is primarily a low‐Phe diet combined with l‐amino acid‐based products (l‐AA). Protein requirements in adults with PKU have not been directly determined.
Abrar Turki   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy